CT
Century Therapeutics Inc
🇺🇸XNAS.IPSCUnited StatesHealthcare
$1.96USDdown -0.02 (-1.01%)OpenDelayed4:14 PM
Price$1.96-0.02 (-1.01%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US15673T1007
- CUSIP
- 15673T100
Company
- Employees
- 78
- Headquarters
- Philadelphia, United States
- Website
- https://www.centurytx.com
- CEO
- Dr. Brent Pfeiffenberger M.B.A., Pharm.D.
Market
- Shares outstanding
- 181.1M
- Market cap
- $354.91M
Highlights
- Market cap
- $354.91M
- EPS LTM
- -$0.61calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -3.23calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$109.79M-371.6%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$88.53M+22.95%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.